| Application no. and date | 06720163.2 (espacenet) (Federated) (European Patent Register), 20060202 | | Patent/reg. no. and date | DK/EP 1848414, 20110406 | | Publication date | 20071031 | | Priority no. and date | US 649483 P, 20050203, US 671989 P, 20050415 | | EP pub. no. and date |
EP 1848414 20071031 | | Effective date | | | Applicant/owner | THE GENERAL HOSPITAL CORPORATION, 55 Fruit Street
Boston, MA 02114, US,
Wyeth LLC, 235 East 42nd Street
New York, NY 10017, US | | Applicant ref. no. | 63149 | | Inventor | HABER, Daniel, 34 Manadnock Road
Chestnut Hill, Massachusetts 02467, US,
SETTLEMAN, Jeffrey E., 140 Waverly Avenue
Newton, Massachusetts 02458, US,
KWAK, Eunice L., 47 Butler Circle
Marlborough, Massachusetts 01752, US,
BELL, Daphne Winifred, 4450 South Park Avenue
Apt. 1706
Chevy Chase, MD 20815, US,
SORDELLA, Raffaella, 1640 Moors Hill Road
Syosset, NY 11791, US,
GODIN-HEYMANN, Nadia G., 21 Home Mead
Stanmore
Middlesex HA7 1AF, GB,
RABINDRAN, Sridhar Krishna, 5206 Sentinel Ridge
Eagleville, PA 19403, US | | Representative | Larsen & Birkeholm A/S Skandinavisk Patentbureau, Banegårdspladsen 1, 1570 København V | | Opponent | | | IPC Class | A61K 31/4706 (2006.01) , A61K 38/17 (2006.01) , A61P 35/00 (2006.01) | | Title | Fremgangsmåde til behandling af gefitinib-resistent cancer | | Int. application no. | US2006003717 | | Int. publication no. | WO2006084058 | | Related patent (certificate) | CA 2016 00033 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
